Mercer Global Advisors Inc Cybin Inc. Transaction History

Mercer Global Advisors Inc

  • $45.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.3 - $0.46 $1,800 - $2,760
6,000 Added 26.09%
29,000 $12,000
Q3 2023

Nov 13, 2023
BUY
$0.29 - $0.63 $6,669 - $14,490
23,000 New
23,000 $12,000
Q1 2022

May 10, 2022
SELL
$0.74 - $1.22 $370 - $610
-500 Reduced 4.0%
12,000 $10,000
Q4 2021

Feb 04, 2022
BUY
$1.13 - $2.31 $14,124 - $28,875
12,500 New
12,500 $15,000

Others Institutions Holding CYBN

# of Institutions
8
Shares Held
66.1K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.58B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email